209 related articles for article (PubMed ID: 30918042)
1. Diversity of KIR, HLA Class I, and Their Interactions in Seven Populations of Sub-Saharan Africans.
Nemat-Gorgani N; Guethlein LA; Henn BM; Norberg SJ; Chiaroni J; Sikora M; Quintana-Murci L; Mountain JL; Norman PJ; Parham P
J Immunol; 2019 May; 202(9):2636-2647. PubMed ID: 30918042
[No Abstract] [Full Text] [Related]
2. HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands.
Ashouri E; Norman PJ; Guethlein LA; Han AS; Nemat-Gorgani N; Norberg SJ; Ghaderi A; Parham P
HLA; 2016 Sep; 88(3):87-99. PubMed ID: 27558013
[TBL] [Abstract][Full Text] [Related]
3. Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans.
Norman PJ; Hollenbach JA; Nemat-Gorgani N; Guethlein LA; Hilton HG; Pando MJ; Koram KA; Riley EM; Abi-Rached L; Parham P
PLoS Genet; 2013 Oct; 9(10):e1003938. PubMed ID: 24204327
[TBL] [Abstract][Full Text] [Related]
4. Distribution of HLA-A, -B, and -C alleles and HLA/KIR combinations in Han population in China.
Shen Y; Cao D; Li Y; Kulski JK; Shi L; Jiang H; Ma Q; Yu J; Zhou J; Yao Y; Shi L
J Immunol Res; 2014; 2014():565296. PubMed ID: 24995346
[TBL] [Abstract][Full Text] [Related]
5. Killer cell immunoglobulin-like receptor (KIR) genes and their HLA-C ligands in a Ugandan population.
Nakimuli A; Chazara O; Farrell L; Hiby SE; Tukwasibwe S; Knee O; Jayaraman J; Traherne JA; Elliott AM; Kaleebu P; Mirembe F; Moffett A
Immunogenetics; 2013 Nov; 65(11):765-75. PubMed ID: 23974321
[TBL] [Abstract][Full Text] [Related]
6. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
7. Genetic study of KIR and HLA ligands in 235 individuals from Northeastern Thailand.
Chaisri S; Leelayuwat C; Romphruk A
Hum Immunol; 2017; 78(5-6):395-396. PubMed ID: 28431957
[TBL] [Abstract][Full Text] [Related]
8. Different Selected Mechanisms Attenuated the Inhibitory Interaction of KIR2DL1 with C2
Nemat-Gorgani N; Hilton HG; Henn BM; Lin M; Gignoux CR; Myrick JW; Werely CJ; Granka JM; Möller M; Hoal EG; Yawata M; Yawata N; Boelen L; Asquith B; Parham P; Norman PJ
J Immunol; 2018 Apr; 200(8):2640-2655. PubMed ID: 29549179
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population.
Paximadis M; Mathebula TY; Gentle NL; Vardas E; Colvin M; Gray CM; Tiemessen CT; Puren A
Hum Immunol; 2012 Jan; 73(1):80-92. PubMed ID: 22074999
[TBL] [Abstract][Full Text] [Related]
10. Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing.
Norman PJ; Hollenbach JA; Nemat-Gorgani N; Marin WM; Norberg SJ; Ashouri E; Jayaraman J; Wroblewski EE; Trowsdale J; Rajalingam R; Oksenberg JR; Chiaroni J; Guethlein LA; Traherne JA; Ronaghi M; Parham P
Am J Hum Genet; 2016 Aug; 99(2):375-91. PubMed ID: 27486779
[TBL] [Abstract][Full Text] [Related]
11. Possible KIR-driven genetic pressure on the genesis and maintenance of specific HLA-A,B haplotypes as functional genetic blocks.
Capittini C; Tinelli C; Guarene M; Pasi A; Badulli C; Sbarsi I; Garlaschelli F; Cremaschi AL; Pizzochero C; Monti C; Salvaneschi L; Martinetti M
Genes Immun; 2012 Sep; 13(6):452-7. PubMed ID: 22573115
[TBL] [Abstract][Full Text] [Related]
12. Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia.
Cooley S; Weisdorf DJ; Guethlein LA; Klein JP; Wang T; Marsh SG; Spellman S; Haagenson MD; Saeturn K; Ladner M; Trachtenberg E; Parham P; Miller JS
J Immunol; 2014 May; 192(10):4592-600. PubMed ID: 24748496
[TBL] [Abstract][Full Text] [Related]
13. [Association of genetic polymorphisms of KIR-HLA system with chronic myeloid leukemia among ethnic Hans from southern China].
Deng Z; Zhen J; Wang D; He L; Zou H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):53-57. PubMed ID: 28186594
[TBL] [Abstract][Full Text] [Related]
14. Distinctive KIR and HLA diversity in a panel of north Indian Hindus.
Rajalingam R; Krausa P; Shilling HG; Stein JB; Balamurugan A; McGinnis MD; Cheng NW; Mehra NK; Parham P
Immunogenetics; 2002 Mar; 53(12):1009-19. PubMed ID: 11904677
[TBL] [Abstract][Full Text] [Related]
15. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
Khanuntong S; Kuptawintu P; Upaisilpsathaporn K; Poolchareon A; Bunworasate U; Hirankarn N
HLA; 2016 Jun; 87(6):422-31. PubMed ID: 27273744
[TBL] [Abstract][Full Text] [Related]
16. KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancer.
Portela P; Merzoni J; Lindenau JD; Damin DC; Wilson TJ; Roesler R; Schwartsmann G; Jobim LF; Jobim M
Hum Immunol; 2017 Mar; 78(3):263-268. PubMed ID: 28088355
[TBL] [Abstract][Full Text] [Related]
17. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.
McQueen KL; Dorighi KM; Guethlein LA; Wong R; Sanjanwala B; Parham P
Hum Immunol; 2007 May; 68(5):309-23. PubMed ID: 17462498
[TBL] [Abstract][Full Text] [Related]
18. KIR diversity in Māori and Polynesians: populations in which HLA-B is not a significant KIR ligand.
Nemat-Gorgani N; Edinur HA; Hollenbach JA; Traherne JA; Dunn PP; Chambers GK; Parham P; Norman PJ
Immunogenetics; 2014 Nov; 66(11):597-611. PubMed ID: 25139336
[TBL] [Abstract][Full Text] [Related]
19. KIR2DS5 allotypes that recognize the C2 epitope of HLA-C are common among Africans and absent from Europeans.
Blokhuis JH; Hilton HG; Guethlein LA; Norman PJ; Nemat-Gorgani N; Nakimuli A; Chazara O; Moffett A; Parham P
Immun Inflamm Dis; 2017 Dec; 5(4):461-468. PubMed ID: 28685972
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
Littera R; Chessa L; Onali S; Figorilli F; Lai S; Secci L; La Nasa G; Caocci G; Arras M; Melis M; Cappellini S; Balestrieri C; Serra G; Conti M; Zolfino T; Casale M; Casu S; Pasetto MC; Barca L; Salustro C; Matta L; Scioscia R; Zamboni F; Faa G; Orrù S; Carcassi C
PLoS One; 2016; 11(1):e0146086. PubMed ID: 26744892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
